Fifth, in a passive-transfer EAE study, several MS risk genes were suggested to be implicated in the transition from in vitro-generated MOG-specific TH17 cells to encephalitogenic CD4+ T cells (33). The gene discussed is MOG; the disease is myeloid sarcoma.